DRUG REGULATION IN INDIA: SWOT ANALYSIS
Abstract
Drug regulation plays pivotal role in any country because the purpose of drug regulation is to promote and to protect public health by ensuring the safety, efficacy and quality of drugs. Drug regulation should cover all products for which medicinal claims are made and all aspects of drugs like manufacturing, import, export, distribution, dispensing, promotion, sell and supply. But unfortunately drug regulation does not meet these requirements in India as legislation omits or exempts certain areas of pharmaceutical activity from the scope of control in India. Although there are so many deficiencies, lacunae and hurdles in Indian drug regulation, there is a wider scope for drug regulation in India because government is taking positive steps to reform it. One can say India is a vast ocean of opportunities. Hence it is tried to analyse the drug regulation of India using the framework of SWOT (Strengths, Weaknesses, Opportunities, Threats). SWOT analysis aids to find out possible ways to overcome the weaknesses and threats, and to utilize the strengths and opportunities properly
Downloads
References
http://www.nature.com/subjects/drug-regulation
2. India Pharmaceutical Regulatory Report 2013 [Internet]. Bethesda [MD]: Pacific Bridge Medical; 2013 [cited 2015 Aug 7]. Available from:
http://www.pacificbridgemedical.com/wp-content/ uploads/2015/04/India-Pharmaceutical-Regulatory-Report-2013.pdf
3. Dr. Singh S. Drugs Controller General (India), Drug Regulations in India, Meeting with Ambassadors / High Commissioners of African Countries [Internet]. New Delhi [India]; 2009. [cited 2015 Aug 8]. Available from:
http://www.pharmexcil.com/data/uploads/Drug%20Regulations%20in%20India%20Dr%20Surinder%20Singh.pdf
4. SWOT Analysis of Indian Pharmaceutical Industry Economics Essay, Essays [Internet]. UK; 2013. [cited 2015 Aug 8]. Available from:
http://www.ukessays.com/essays/economics/swot-analysis-of-indian-pharmaceutical-industry-economics-essay.php?cref=1
5. Nayak N. Competition impediments in the pharmaceutical sector in India, background paper prepared for the National Competition Policy [Internet]. India: Indian Institute of Corporate Affairs; 2011, 6-8. [cited 2015 Aug 12]. Available from: http://circ.in/pdf/Pharmaceuticals_Sector.pdf
6. Iyer PK. Regulatory Issues in the Indian Pharmaceutical Industry, India Science and Technology: 2008 [Internet]. National Institute of Science, Technology and Development Studies, India: CSIR; 2009, 212-9 [cited 2015 Aug 13]. Available from:
http://www.nistads.res.in/indiasnt2008/t4industry/t4ind18.htm
7. Shirodkar SN. Centre allots Rs. 1750-cr to CDSCO to strengthen drug regulatory system across the country [Internet]. India:PHARMABIZ.com; 2014 July 07 [cited 2015 Sept 4]. Available from:
http://pharmabiz.com/ArticleDetails.aspx?aid=82785&sid=1
8. Bhatt A. Clinical Trials in India: SWOT Analysis [Internet]. UK: ClinInvent Research Pvt Ltd; 2006 Apr. [cited 2015 Aug 14]. Available from:
http://www.clininvent.com/clininvent/Presentation/DrBhatt-IndiaSWOT-Apr06.pdf
9. India Pharmaceutical Regulatory Report 2013 [Internet]. Bethesda [MD]: Pacific Bridge Medical; 2013 [cited 2015 Aug 7]. Available from:
http://www.pacificbridgemedical.com/research-report/india-pharmaceutical-report-2013/
10. Karve SJ, Joshi AV. SWOT Analysis of Indian Pharmaceutical Industry [Internet]. Pharmabiz.com; 2002 [cited 2015 Aug 18]. Available from:
http://saffron.pharmabiz.com/article/detnews.asp?articleid=16738§ionid=50
11. Sahgal C. Indian Pharmaceutical Industry [Internet]. Health & Medicine, Business, News & Politics; 2013. [cited 2015 Aug 18]. Available from:
http://www.slideshare.net/chandnisahgal/indian-pharmaceutical-industry-25516641?qid=f9297aae-b04d-452f-8786-ce3a930c08b9&v=qf1&b=& from_search=1#stats-panel
12. BMS Team, SWOT Analysis of Indian Pharmaceutical Sector [Internet]. India: BMS.co.in; 2013 [cited 2015 August 20]. Available from:
http://www.bms.co.in/swot-analysis-of-indian-pharmaceutical-sector/
13. Kumar K, Kulshreshtha MK. SWOT analysis of Indian pharmaceutical industry, International Journal of Marketing [Internet]. 2013. [cited 2015 Aug 27]; 2(5):26-33. Available from:
www.indianresearchjournals.com
14. Indian pharma: A SWOT analysis [Internet]. rediff.com; 2004 [cited 2015 Aug 31]. Available from: http://www.rediff.com/money/report/pharma/20040624.htm
15. Mezher M. India Takes Inspiration From FDA, EMA in Bid to Improve CDSCO [Internet]. Rockville [MD]: Regulatory Affairs Professionals Society; 2015[cited 2015 Aug 31]. Available from:
http://www.raps.org/Regulatory-Focus/News/2015 /06/29/22795/India-Takes-Inspiration-From-FDA-EMA-to-Improve-CDSCO/.aspx#sthash.jzyiqP5j. dpuf
16. India's drug regulation system in a total shambles [Internet]. New Delhi [India]: Mail Today Science Bureau; 2012 [cited 2015 Sept 7]. Available from:
http://indiatoday.intoday.in/story/drug-regulation-system-in-india-is-in-a-shambles-dcgi/1/187918.html
17. Raju A. Indian regulatory system needs to be strengthened to improve clinical trial industry in India: Neuland labs CFO [Internet]. India: Pharmabiz.com; 2014 Dec 23 [cited 2015 Sept 8]. Available from:
http://www.pharmabiz.com/ArticleDetails.aspx?aid=85815&sid=1
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM
